Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Diversify Caterpillar holdings with tax-efficient strategies. Explore HD, LOW, and SNA for income replacement potential and ...

The White House pulled the nomination of former Rep. Dave Weldon, (R-FL), to head the Centers of Disease Control and Prevention on Thursday morning, just hours before he was set to appear before the ...

On March 4, 2025, filings revealed that CEO Stephane Bancel purchased 160,314 shares of MRNA stock between $31.04 and $31.53, ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug ...

Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...

As digital channels become the backbone for sharing information and facilitating school-to-home connections, Edlio, a leading provider of technology ...

Q3 2025 Earnings Call Transcript March 6, 2025 John Wiley & Sons, Inc. beats earnings expectations. Reported EPS is $0.84, expectations were $0.65. Operator: Good morning, and welcome to Wallace Q3 ...

Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...